Huntington National Bank’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14 | Hold |
1
| – | – | ﹤0.01% | 3802 |
|
|
2026
Q1 | $14 | Hold |
1
| – | – | ﹤0.01% | 3636 |
|
|
2025
Q4 | $14 | Hold |
1
| – | – | ﹤0.01% | 3549 |
|
|
2025
Q3 | $8 | Hold |
1
| – | – | ﹤0.01% | 3762 |
|
|
2025
Q2 | $6 | Sell |
1
-39
| -98% | -$252 | ﹤0.01% | 3827 |
|
|
2025
Q1 | $326 | Sell |
40
-296
| -88% | -$2.74K | ﹤0.01% | 2539 |
|
|
2024
Q4 | $3.16K | Buy |
336
+120
| +56% | +$1.25K | ﹤0.01% | 2135 |
|
|
2024
Q3 | $2.31K | Hold |
216
| – | – | ﹤0.01% | 2208 |
|
|
2024
Q2 | $2.14K | Buy |
216
+138
| +177% | +$1.42K | ﹤0.01% | 2146 |
|
|
2024
Q1 | $919 | Buy |
78
+20
| +34% | +$256 | ﹤0.01% | 2295 |
|
|
2023
Q4 | $823 | Buy |
58
+57
| +5,700% | +$647 | ﹤0.01% | 2247 |
|
|
2023
Q3 | $12 | Hold |
1
| – | – | ﹤0.01% | 3359 |
|
|
2023
Q2 | $13 | Hold |
1
| – | – | ﹤0.01% | 3309 |
|
|
2023
Q1 | $11 | Hold |
1
| – | – | ﹤0.01% | 3204 |
|
|
2022
Q4 | $12 | Hold |
1
| – | – | ﹤0.01% | 3044 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2128 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2155 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2137 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2103 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1853 |
|
|
2021
Q2 | $0 | Sell |
1
-737
| -100% | -$7.19K | ﹤0.01% | 1771 |
|
|
2021
Q1 | $7K | Sell |
738
-38
| -5% | -$588 | ﹤0.01% | 1403 |
|
|
2020
Q4 | $18K | Sell |
776
-64
| -8% | -$1.31K | ﹤0.01% | 1153 |
|
|
2020
Q3 | $12K | Buy |
840
+839
| +83,900% | +$12.2K | ﹤0.01% | 1181 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1565 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1626 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1722 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1595 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | +$13 | ﹤0.01% | 1640 |
|
Other funds holding FOLD
Huntington National Bank's FOLD Position: Q2 2026 in Review
Huntington National Bank held its Amicus Therapeutics (FOLD) position steady in Q2 2026 at 1 share worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3802.
Huntington National Bank first reported a position in FOLD in Q2 2019 and has held it in 29 quarters since. The position peaked at $18K in Q4 2020. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- Huntington National Bank held 1 share of Amicus Therapeutics worth $14 as of Q2 2026.
- Huntington National Bank left its Amicus Therapeutics share count unchanged in Q2 2026.
- Amicus Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #3802 holding.
- Huntington National Bank first reported a position in Amicus Therapeutics in Q2 2019 and has held it in 29 quarters since.
- Huntington National Bank's Amicus Therapeutics position peaked at $18K in Q4 2020.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.